Mauna Kea Technologies SAS (MKEA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mauna Kea Technologies SAS (MKEA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3446
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicroscopy platform that provides microscopic images of tissue instantaneously and in a minimally-invasive way. The company also offers vasculature and vasodynamics studies, longitudinal monitoring of disease progression and in vivo histology. It provides technical support and training. MKT’s products are used for treatment of digestive diseases and diagnosing respiratory diseases and also used in laboratories for research on small animals. The company has presence in North America, Europe and Asia. MKT is headquartered in Paris, France.

Mauna Kea Technologies SAS (MKEA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Mauna Kea Technologies to Raise USD9.1 Million in Public Offering of Shares 11
Mauna Kea Technologies to Raise USD5.7 Million in Public Offering of Shares 12
Debt Offering 13
Mauna Kea Tech Raises USD4.3 Million in First Tranche of Private Placement of Bonds Due 2022 13
Mauna Kea Technologies SAS – Key Competitors 14
Mauna Kea Technologies SAS – Key Employees 15
Mauna Kea Technologies SAS – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Sep 20, 2017: Mauna Kea Technologies Reports First Half 2017 Financial Results 17
Jul 25, 2017: Mauna Kea Technologies Reports First Half 2017 Sales 19
Apr 19, 2017: Mauna Kea Technologies Reports First Quarter 2017 Sales 20
Mar 23, 2017: Mauna Kea Technologies Reports Full Year 2016 Financial Results And Highlights 2017 Key Priorities 21
Jan 24, 2017: Mauna Kea Technologies Reports Fourth Quarter and Full Year 2016 Sales 23
Corporate Communications 24
Apr 05, 2018: Appointment of Christophe Lamboeuf to the position of Chief Financial Officer 24
Jan 15, 2018: Mauna Kea Technologies Appoints Experienced Healthcare Executive, Molly O’Neill, to Board of Directors 25
Oct 17, 2017: Mauna Kea Technologies Appoints Olivier Regnard as Deputy CEO And Chief Financial Officer 26
Mar 13, 2017: Mauna Kea Appoints Jennifer F. Tseng, M.D. to Board of Directors 27
Other Significant Developments 28
Jul 25, 2018: Mauna Kea Technologies Reports Second Quarter and First Half 2018 Sales 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mauna Kea Technologies SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Mauna Kea Technologies to Raise USD9.1 Million in Public Offering of Shares 11
Mauna Kea Technologies to Raise USD5.7 Million in Public Offering of Shares 12
Mauna Kea Tech Raises USD4.3 Million in First Tranche of Private Placement of Bonds Due 2022 13
Mauna Kea Technologies SAS, Key Competitors 14
Mauna Kea Technologies SAS, Key Employees 15
Mauna Kea Technologies SAS, Subsidiaries 16

List of Figures
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Mauna Kea Technologies SAS (MKEA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nostrum Oil & Gas PLC (NOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Nostrum Oil & Gas PLC (Nostrum) is an independent oil and gas company. It produces, develops, and explores for oil and gas in the pre-Caspian Basin. The company produces crude oil, stabilized liquid condensate, LPG and dry gas. Nostrum has commercial hydrocarbon reserves in the Ardatovski, L …
  • Arca Continental SAB de CV:戦略・SWOT・企業財務分析
    Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Rafael Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rafael Pharmaceuticals Inc (Rafael Pharmaceuticals), a subsidiary of IDT Corp is a healthcare products provider that offers therapeutics. The company develops drug therapies for the treatment of cancer. It provides altered energy metabolism directed platform for cancer cell energy metabolism …
  • NovoCure Ltd (NVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析
    AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sony Mobile Communications AB.:企業の戦略的SWOT分析
    Sony Mobile Communications AB. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Generex Biotechnology Corp (GNBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company’s proprietary liquid formulatio …
  • Acura Pharmaceuticals Inc (ACUR)-医療機器分野:企業M&A・提携分析
    Summary Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company that researches, develops, and commercializes tamper-resistant products to prevent the abuse and misuse of medication. The company’s proprietary technologies, Aversion, Limitx and Impede, are used to prevent product tamp …
  • Willis Towers Watson Public Ltd Co:戦略・SWOT・企業財務分析
    Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report Summary Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • National HealthCare Corp (NHC):企業の財務・戦略的SWOT分析
    Summary National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing care, Alzheimer's and memory care, residential and assisted living, home care, hospice care and long term care insurance …
  • Timberwest Forest Corporation:企業の戦略・SWOT・財務分析
    Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report Summary Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • J D Wetherspoon plc (JDW):企業の財務・戦略的SWOT分析
    J D Wetherspoon plc (JDW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nippon Chemiphar Co Ltd (4539):企業の財務・戦略的SWOT分析
    Summary Nippon Chemiphar Co Ltd (Nippon Chemiphar) is a provider of pharmaceutical drugs and health-related services. The company manufactures, supplies, imports and exports ethical pharmaceuticals and diagnostic agents. Nippon Chemiphar offers diagnostic products, such as IgE NC, a diagnostic kit t …
  • Solidarity Bahrain B.S.C.:企業の戦略・SWOT・財務情報
    Solidarity Bahrain B.S.C. - Strategy, SWOT and Corporate Finance Report Summary Solidarity Bahrain B.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Fresenius Kabi USA LLC:企業の戦略的SWOT分析
    Fresenius Kabi USA LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Olympus America Inc:医療機器:M&Aディール及び事業提携情報
    Summary Olympus America Inc (Olympus America), a subsidiary of Olympus Corporation is medical device company that designs, develops and manufactures medical and surgical products, industrial measurement and imaging instruments, life science imaging systems, and cameras and audio products. The compan …
  • China Resources Beer (Holdings) Co Ltd:戦略・SWOT・企業財務分析
    China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Pacgen Life Science Corp (PBS):企業の財務・戦略的SWOT分析
    Summary Pacgen Life Science Corp (Pacgen), formerly Pacgen Biopharmaceuticals Corp, is a life science technology company that develops and commercializes biomedical products and services. The company offers development of novel therapeutic drug candidates. It provides product such as include amino-a …
  • Paramount Resources Ltd (POU):企業の財務・戦略的SWOT分析
    Summary Paramount Resources Ltd (Paramount Resources) is an energy company that offers exploration, production, development, and marketing of oil and gas products. The company offers products such s crude oil, fuel oil, natural gas and natural gas liquids. It operates in three segments such as princ …
  • Senseonics Inc:企業の戦略的SWOT分析
    Senseonics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆